课题基金 / 基金详情

Robust trans-synaptic labeling technologies for cell type-specific quantitation of synaptic connectivity

Robust trans-synaptic labeling technologies for cell type-specific quantitation of synaptic connectivity
强大的跨突触标记技术,用于突触连接的细胞类型特异性定量
批准号:
8935699
负责人:
EDWARD M CALLAWAY
金额:
$37.74万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-21 至 2020-06-30

项目摘要

项目成果

EDWARD M CALLAWAY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Neural circuits are composed of networks of specific cell types that are interconnected in precise patterns to give rise to normal brain function. Past studies have investigated the rates of connections that are formed by cultured neurons in vitro and these have revealed abnormalities both in a mouse model of autism (MeCP2 KO mice) and for human induced pluripotent stem cell (hiPSC)-derived neurons from schizophrenic patients (Brennand et al., 2011). But simple separation of cortical neurons into just excitatory versus inhibitory groups barely scratches the surface of the diversity of cortical cell types, the known specificity of connections between specific cell types in the abnormal or normal brain. In Project 5 we propose to develop and then implement novel tools that will allow assays of the cell-type specificity of connections that are formed in cultures of hiPSC- derived neurons. These assays are based on the use of glycoprotein deleted rabies viruses for trans-synaptic labeling of connected neurons, and conditional expression of EnvA/TVA targeting systems for directing the initial infection of rabies virus to specific cell types (Wickersham et al., 2007b; Marshel et al., 2010; Wall et al., 2010)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic access to cortical cell types with epigenetic assays and high-throughput, low-cost enhancer screening
Genetic access to cortical cell types with epigenetic assays and high-throughput, low-cost enhancer screening
Anatomical and Functional Interrogation of Parallel Visual Pathways from Eye to Brain
Genetic access to cortical cell types with epigenetic assays and high-throughput, low-cost enhancer screening
海外基金